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Edited by Gianni CesareniAbstract cGMP-phosphodiesterase (PDE) is a key component
in visual phototransduction. Rod and cone photoreceptors each
produce their unique cGMP-PDE subunits. The a0 catalytic
subunits are believed to be cone-speciﬁc. In this study, we report
that transfection of the )132 to +139 sequence in the upstream
region of the human a0-PDE gene fused to luciferase cDNA gives
the highest level of reporter gene transcription in cultured
retinoblastoma Y79 cells. Transgenic Xenopus laevis carrying
this sequence fused to green ﬂuorescent protein (GFP) expressed
GFP in cones, suggesting a conserved regulatory mechanism for
a0-PDE transcription in both human and frog.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Phototransduction begins when the visual pigments of rods
and cones absorb light. A cascade of events transforms bio-
chemical reactions into a set of neuronal responses detected by
the brain. A key step in this process is the binding of visual
pigment-activated transducin to the inhibitory c-subunit of the
corresponding cyclic GMP-phosphodiesterase (PDE), which
allows the catalytic subunits of the PDE to hydrolyze thou-
sands of cyclic GMP molecules to 50-GMP. Decreased levels of
cyclic nucleotide lead to the closure of cGMP-gated cationic
channels and changes in cell membrane potential and photo-
receptor signaling [1]. Therefore, by hydrolyzing cyclic GMP,
PDE plays a pivotal role in phototransduction.
The PDE enzyme complex has two inhibitory and two cat-
alytic subunits. There are three separate genes encoding the
catalytic subunits [2–4]. Biochemical evidence supports the fact
that rod and cone photoreceptors each express a unique PDE* Corresponding authors. Fax: +1-315-464-8750 (B.E. Knox); +1-310-
794-7904 (D.B. Farber).
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doi:10.1016/j.febslet.2004.10.008complex [5,6]. In rods, there are two separate catalytic sub-
units, a and b, while in cones, the two catalytic subunits, a0, are
identical [6,7]. We have previously cloned and characterized
the human a0-PDE gene, which has 22 exons spanning 48 kb of
genomic DNA. One of the clones isolated at that time con-
tained approximately 1 kb of 50 ﬂanking region [8].
In this report, we characterized the promoter of the human
a0-PDE gene using a human retinoblastoma-derived cell line
(Y79) and transgenic Xenopus laevis. Y79 retinoblastoma cells
have been shown to express cone a0-PDE mRNA [9] and its
functional protein [10]. We show here that a construct con-
taining 132 bp of the a0-PDE gene 50 ﬂanking region is suﬃ-
cient to drive luciferase reporter gene expression in Y79 cells.
In the diﬀerentiated frog retina, we ﬁnd that this minimal
promoter drives the expression of reporter gene speciﬁcally in
cone photoreceptors. In some transgenic frogs, we also ob-
served expression in a subset of bipolar cells. These results
highlight conserved cone transcriptional regulation of cone
phototransduction machinery in vertebrates and also suggest
some possible common regulatory factors between cones and
bipolar cells.2. Materials and methods
2.1. Reporter gene constructs
The a0-PDE 50 ﬂanking region was obtained from a previously
characterized human genomic DNA clone (a03), which contains 989 bp
from the translation start site [8]. Sequence speciﬁc primers, one with
NheI (N48, GGGCTAGCCCTAACTAAGATACTTAGCAG) and
the other with BglII (B61, GGAGATCTGGTGTGGCTTGCTTTG-
CTGC) restriction enzyme sites, were designed to amplify and sub-
clone an 870 bp fragment ()731/+139) into the multicloning region of
a luciferase reporter gene vector, pGL2-Basic (Promega, Madison,
WI). PCRs were carried out as follows: 30 cycles of denaturation
(1 min at 95 C), annealing (1 min at 60 C) and extension (2 min and
30 s at 72 C) in a Robocycler 40 (Stratagene).
Unidirectional nested set deletions from the 870 bp PCR-ampliﬁed
a0-PDE 50 ﬂanking region clone were obtained using the Erase-a-Base
System (Promega), based on a procedure developed by Henikoﬀ [11].
To protect vector cleavage and allow sequential deletions of the 50 end
of the insert, the necessary 30 overhang in the pGL2-Basic vector and
the 50 overhang in the insert were created by cutting KpnI and NheI
restriction enzyme sites, respectively. Once the DNA was prepared,
deletions were made according to the protocol (Promega). Incubation
was then carried out at 22 C and samples were removed every 30 s to
stop the reaction. The resulting fragments were sequenced.
The )132/+139-pGL2 construct was subcloned into a pEGFP vector
using EcoRI and KpnI. The resultant )132/+139-pEGFP construct wasblished by Elsevier B.V. All rights reserved.
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was used for transgenic Xenopus generation.
2.2. Cell cultures and transﬀections
All cell lines described below were obtained from American Type
Culture Collection (Rockville, MD). Human retinoblastoma Y79 cells
(HTB18) were maintained in RPMI 1640 medium containing L-glu-
tamine supplemented with 15% fetal bovine serum (Gibco-BRL,
Gaithersburg, MD). These cells were grown in suspension and plated
for transfection experiments in a monolayer as described [12]. 293
human embryonic kidney cells and HeLa cells were cultured in
DMEM supplemented with 10% fetal bovine serum, penicillin G (100
U/ml), streptomycin (100 lg/ml) and amphotericin B (0.25 lg/ml) [13].
SY5Y human neuroblastoma cells were cultured with the same sup-
plements as HeLa and 293 cells, but in DMEM/F12 (50% of each v/v)
instead of just DMEM. All four cell lines were transfected using the
calcium phosphate precipitation method [12,14]. However, HeLa, 293
and SY5Y cells were transfected for 4.5 h instead of the 16 h used for
Y79 cells, since longer incubation with calcium phosphate mixture
proved toxic to these cells. Transfections were carried out using 15 lg
of the experimental construct [either the pGL2-Control (an SV40
promoter and enhancer-driven luciferase reporter gene construct) or
one of the human cone a0-PDE constructs], and 5 lg of an internal
control construct, pSV-b-Gal (an SV40 promoter-driven lacZ gene
construct) used for normalization of transfection eﬃciency. As a
negative control, cells were either transfected with calcium phosphate
and 15 lg of the pGL2-Basic vector or with water (no DNA). Cells
were harvested and lysed in 100 ll of 1· Reporter Lysis Buﬀer (Pro-
mega) 24 h after transfection. Assays for both luciferase and b-galac-
tosidase were performed as described [12]. Each experiment consisted
of the experimental a0-PDE-luciferase constructs transfected in three
separate plates alongside triplicate transfections of the control SV40-
luciferase (positive control) and also, vector only (negative control)
constructs, each normalized with SV40-lacZ. ‘Percent of normalized
SV40 driven luciferase activity’ was calculated by dividing the lucif-
erase activity of cells transfected with a given construct by their b-
galactosidase activity (expressed by the co-transfected SV40-driven
LacZ gene construct) and dividing this value by the average activity
obtained with the normalized SV40-driven construct. We analyzed the
data with the ANOVA (single factor) test (Microsoft Excel 2004) to
determine statistical signiﬁcance.
2.3. Electrophoretic mobility shift assay
The double stranded oligonucleotide, )132/)111, probe was made
by ﬁrst end-labeling the sense strand, 50-CTAGTACTAATG-
CTCAGGGATTTAGT-30, with [c-32P]dATP and RTS T4 polynu-
cleotide kinase (Gibco-BRL), purifying it with a Sephadex G-25 spin
column and then annealing it to the antisense strand, 50-CTA-
GACTAAATCCCTGAGCATTAGTA-30, as previously described
[15]. Twenty-ﬁve lg of Y79 cell nuclear extract was prepared [15] and
bound to a non-speciﬁc competitor (1 lg of poly-dIdC) for a few
minutes before adding the cold competitor and radiolabeled probe
(1.5 105 cpm) in a total volume of 20 ll. Binding reactions were
incubated at room temperature for 30 min and the products were re-
solved on a 8% non-denaturing polyacrylamide gel with 2.5% cross-
linking. Gels were electrophoresed in 0.25· Tris-borate buﬀer at 15 mA
for 16 h, dried and exposed to Hyperﬁlm (Amersham).
2.4. Transgenic frog generation
X. laevis oocytes were obtained from hormonally induced females
and dejellied with 2% cysteine in 1·MMR (0.1 M NaCl, 2 mM KCl, 1
mM MgSO4, 2 mM CaCl2, 5 mM HEPES, pH 7.8, and 2.5 lg/ml
gentamycin). Transgenic embryos were generated in four separate ex-
periments using restriction enzyme-mediated integration (REMI) as
previously described [16]. In each experiment, normal embryos were
selected and grown to stage 39–43 at 18 C in 0.1· MMR. At these
stages, embryos that expressed green ﬂuorescent protein (GFP) above
the background auto-ﬂuorescence detected in the yolk were selected.
The embryos were then grown for another month at 18 C in 0.1X
MMR and then anesthetized, tail snips taken and frozen on dry ice.
The remaining embryo was ﬁxed in 4% paraformaldehyde for 1 h and
incubated in 20% sucrose at 4 C overnight. The next day, they were
mounted in O.C.T., frozen and cryostat sectioned (10–14 lm). Im-
munocytochemistry was performed on the sections and these were
visualized using bright ﬁeld and ﬂuorescence on the Nikon Microphot-FX microscope. The confocal images were acquired using the Nikon
Eclipse E600 microscope coupled to a BioRad MRC 1024ES scanning
transmission assembly. LaserSharp 2000 image acquisition software
(BioRad) recorded successive z-axis serial sections to obtain the ﬁnal
images.
Genomic DNA was extracted from each tail snip using the DNeasy
Tissue kit (Qiagen). To determine which embryos were carrying the
transgene, PCR was performed using 1 lM kanamycin sequence-spe-
ciﬁc primers [forward, GATGGATTGCACGCAGGTTC and reverse,
CGATAGAAGGCGATGCGCTGC] and 50 ng DNA in a standard
25 ll PCR (200 lM dNTPs, Promega 1· Reaction Buﬀer with MgCl2
and 0.75 units Promega Taq DNA polymerase). The reactions were
run on a RoboCycler Gradient temperature cycler (Stratagene) un-
der the following conditions: 95 C denaturing for 3 min; 30 cycles of
95 C denaturing for 1 min, 52 C annealing for 1 min and 72 C
extension for 1 min; ﬁnished with one cycle at 72 C for 5 min. The
reactions were analyzed for the presence of the correct-sized PCR
product using gel electrophoresis.
2.5. Immunocytochemistry
Cryostat sections were placed on Superfrost*/Plus microscope slides
(Fisher Scientiﬁc) and dried at room temperature for 30 min to 2 h.
Afterwards, they were stored at 4 C for up to 2 weeks until tail snips
were processed. Cryostat sections were rehydrated in 1· PBS for 3 min
and ﬁxed to slides using 100% methanol for 10 min, then rinsed in 1·
PBS for 2 min and washed 3 times for 5 min in PBST (1· PBS+0.1%
Triton). The slides were blocked for 30 min with PBST+5% heat in-
activated goat serum and incubated at 37 C for 30 min with two
primary antibodies [1:3000 dilution of the mouse anti-rhodopsin an-
tibody (4D2; [16,17]) and a 1:500 dilution of rabbit polyclonal anti-
GFP IgG antibody (Molecular Probes cat#A-11122)] in PBST+5%
HIGS. Sections were washed in PBST 5 times for 3 min and incubated
with 1:750 dilution of goat anti-mouse IgG-Cy3 and 1:500 dilution of
donkey anti-rabbit IgG-Alexa-488 (Molecular Probes; cat#A-21206)
secondary antibodies in PBST+5% HIGS for 2 h at room tempera-
ture. The sections were washed again 3 times for 3 min in PBST and
mounted in FluorSave (CalBioChem) and 2% DABCO (Sigma), dry-
ing overnight at room temperature.3. Results and discussion
3.1. Analysis of the human a0-PDE promoter in cultured cells
We chose to transfect human Y79 retinoblastoma cells for
our initial transcriptional analysis, since this immortalized cell
line normally expresses the cone a0-PDE gene and its func-
tional protein [9,10]. In order to determine the region(s) of the
50 ﬂanking sequence regulating the human a0-PDE gene, we
cloned a fragment containing 731 bp of the 50 ﬂanking region
and 139 bp of the 50untranslated region upstream of luciferase.
We also made a series of 50 deletions and numbered each of the
constructs based on the transcription start site (+1). The )731/
+139 construct consistently drove luciferase activity above the
promoter-less control and to a substantial fraction of the SV40
viral promoter (51 15%) in three separate experiments (data
not shown). An experiment which compared the relative lu-
ciferase activity driven by all the a0-PDE deletion constructs is
shown in Fig. 1A. There was no statistically signiﬁcant change
in activity when nucleotides )731 to )193 were deleted. All
these constructs drove high luciferase expression, although not
as strong as that obtained with the SV40 promoter (Fig. 1A),
demonstrating that these fragments contain sequences required
for transcription in Y79 cells. Deletion analysis showed that
the highest reporter gene activity was observed with the )132/
+139 bp construct. This implies that the sequence between
)731 and )133 may contain transcriptional repressor binding
sites. Repressor cis-acting elements have been reported in the 50
ﬂanking region ()807 to )176) of another cone photoreceptor-
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tion of corresponding constructs into WERI-Rb1 retinoblas-
toma cells [18]. It is possible that transcriptional
repression plays a role in regulating gene expression in cone
photoreceptors.
Removal of an additional 22 bp from the a0-PDE )132/+139
construct reduced expression by 68% (Fig. 1A: )110/+139),
suggesting that a strong positive regulatory factor (or factors)Fig. 1. Relative luciferase activity expressed by constructs containing diﬀeren
transfection into (A) human retinoblastoma Y79 cells, (C) human neuroblast
cells. On the left are schematic representations of the experimental constructs
graph the average percent relative luciferase activity of at least three separate t
the non-retinal cell lines (C) with error bars indicating standard error. Asteri
within the experimental group. (B) Electrophoretic gel shift assay with Y79
with 10 times (lane 2) and 35 times (lane 3) unlabeled )132/)111 double strbinds to this region. The a0-PDE gene does not contain a
TATA box [8] and thus transcriptional sequences may be
found in the 50-untranslated region. Interestingly, a construct
in which the 50 ﬂanking region was removed (construct +1/
+139 bp) still retained about 40 9% of the activity of the full
length fragment, statistically signiﬁcant from the vector alone
(7 1%; P-value¼ 0.01). This suggests that the 50 untranslated
region may contribute to the transcriptional regulation of conet lengths of the human cone a0-PDE 50 ﬂanking region upon transient
oma (SY5Y), cervical cancer (HeLa) and 293 embryonic kidney (HEK)
used. The SV40 promoter served as a positive control. The value bars
ransfection experiments (A) and one transfection experiment in each of
sk indicates construct that is statistically signiﬁcant (P-value< 0.00001)
cell nuclear extract and radiolabeled )132/)111 probe competed away
anded DNA.
Fig. 2. The a0-PDE promoter directs expression in Xenopus cones. (A–
F) Xenopus embryos (stage 43) carrying the )132/+139 a0-PDE+GFP
transgene (A–D) express GFP in the eye (arrow) while a sibling, non-
transgenic embryo (E, F) does not. Note the autoﬂuorescence in the
yolk of all embryos. (G–K) Retinal cryosections (12 lm) of one month
old embryos stained with GFP and rhodopsin antibodies show that
GFP-positive cells are only photoreceptors. (I–K) Confocal images of
section in panel G at higher magniﬁcation. (K), staining of rod pho-
toreceptors by antibodies against rhodopsin. (I) Staining of cone
photoreceptors by anti-GFP antibodies. (J) Overlay of both the anti-
rhodopsin and anti-GFP antibody stainings shows that GFP-positive
cones are distinct from rhodopsin containing rods (K). (L, M) Cross-
sections of transgenic positive (L) and negative (M) tadpole brain at
stage 39, stained with GFP antibody. Arrow points to pineal in both
sections, while arrowheads in L point to GFP-positive cone cells.
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including the a- and b-PDE genes [19].
To identify whether there were proteins in Y79 cell nuclear
extracts that could bind the 22 bp region, we performed gel
shift assays. Three protein–DNA complexes were observed
(Fig. 1B) that were eﬀectively competed with unlabeled probe.
A much larger concentration of the cold oligonucleotide (100–
500X) was necessary to compete with the protein–DNA
complex D (data not shown). Sequence analysis of cis-acting
elements within this 22 bp region using MatInspector (Matrix
family library version 4.2; http//:www.genomatix.de/cgi-bin/
matinspector/matinspector.pl) showed one potential binding
site for an Otx family member (core consensus binding site:
ATTA at )129 to )126). An additional Otx binding site was
also found at )94 to )91. Both Otx family members, Otx2 and
Crx, are expressed in the retina and are important in photo-
receptor formation. Our results suggest a role for Crx in ac-
tivating the a0-PDE promoter as we have shown previously
that Crx can activate the )132/+139 construct in 293 human
embryonic kidney cells [20].
The same constructs were also transiently transfected into a
variety of non-retina-derived cells to test for retinal speciﬁcity
(Fig. 1C). In each cell-line, the SV40 control construct drove
luciferase expression to levels equal to those in Y79 cells.
However, when neuroblastoma, HeLa and 293 human em-
bryonic kidney cells were transfected with the human cone a0-
PDE constructs, luciferase expression was similar to that
produced by the vector alone – only the )401/+139 construct
caused a small increase in luciferase activity in neuroblastoma
cells, comparable to that driven by the +64/+139 construct in
Y79 cells. The rest of the a0-PDE constructs drove luciferase
expression at consistently low levels among the triplicate
plates. Therefore, it appears that a short construct, )132/+139,
is suﬃcient to support reporter gene expression in a retinal cell
line but not in a neural, ovarian or kidney cell line. This sug-
gests that the )132/+139 construct has the elements necessary
for strong expression of cone a0-PDE and may include ele-
ments required for retina-speciﬁc expression.
Several other genes expressed in cone photoreceptor cells
have also been tested in retinoblastoma cell lines. Cone pho-
toreceptor-speciﬁc GNAT2 upstream sequence is able to drive
reporter gene expression with equal intensity in WERI-Rb1
retinoblastoma cells and human 293 cells [18], while cone
arrestin upstream sequences direct expression of a reporter
gene in WERI-Rb1 and Y79 cells but have not been tested in
other cell lines [21]. Human cone red and green visual pigment
genes are expressed in WERI but not Y79 cells. In WERI cells,
reporter gene expression can be activated 2–4 times more ef-
fectively using the green visual pigment regulatory region than
the red [22]. Human interphotoreceptor retinoid binding pro-
tein (IRBP) is expressed in rods, cones and pinealocytes; its
upstream sequence drives expression of a reporter gene in
WERI-Rb1 but not in HeLa cells [23]. In order to test whether
cone a0-PDE could direct retina-speciﬁc expression in vivo, we
generated transgenic X. laevis with the )132/+139 construct.
3.2. Human a0-PDE promoter drives retina-speciﬁc expression
in transgenic Xenopus
We produced transgenic Xenopus using the REMI approach
with a DNA construct containing )132/+139 bp a0-PDE fused
to GFP (a0-PDE promﬁGFP). Under a ﬂuorescent dissecting
microscope, GFP was observed only in the eye beginning atstage 39–40 and ﬂuorescence intensity increased slightly at
later stages (Fig. 2A–F). We cannot exclude the possibility that
there were very low levels of expression (below our detection
level) in other areas of the tadpole. GFP expression level was
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[24]. At approximately one month, expression was observed
only in the outer portion of the retina (Fig. 2G). Anti-GFP
staining was found in cone cells and was distinct from the anti-
rhodopsin staining (Fig. 2I–K). Thus, a small fragment of the
a0-PDE promoter ()132/+139) is capable of selectively direct-
ing gene expression to cone photoreceptors in transgenic
Xenopus.
Interestingly, in some young embryos (stage 39/40), we did
detect weak GFP expression in developing pinealocytes
(Fig. 2L). Ectopic pineal expression has also been observed in
transgenic frogs harboring the Xenopus rhodopsin promoter
driving GFP, yet rhodopsin is undetectable in the pineal [25].
Further experiments will be required to interpret the pineal
expression.
In other animals, we also observed expression of GFP in
cells at the outer edge of the inner nuclear layer that ap-
peared to be bipolar cells, with processes that spanned the
INL from the pedicles of the photoreceptor layer to the tips
of the ganglion cell dendrites (inlay Fig. 3C). A quantitative
analysis was performed on a total of 21 tadpoles, 16
transgene positive (animals 1–16) and 5 negative (animals
C1–C5, Fig. 3A). We counted the number of GFP-positive
retinal cells within the space covered by 25–30 rhodopsin-
positive cells in the center of a lens-containing retinal sec-
tion (Fig. 3A). Animals not carrying the transgene did not
express GFP (Fig. 2E–F, H; 3A and E). We found animals
with only GFP-positive cones (e.g. Fig. 2). The retinas of
these animals exhibited fairly uniform expression in every
cone photoreceptor. A few animals exhibited mostly bipolar
cell expression in a highly mosaic pattern (Fig. 3B and C).
Most animals exhibited at least some cone expression. These
results suggest that transgene insertion site may inﬂuence
the precise expression pattern in individual transgenic
animals.Fig. 3. Transgenic a0-PDE promﬁGFP X. laevis embryos also express GFP
positive bipolar (BP) or cones cells to rhodopsin-positive rod cells. (A, inset)
were made. The number of rods and GFP-positive cone, BP were determined
were counted. (B) An example of a transgenic X. laevis (sample 6) animal tha
cones (arrowhead). (C) Inlay shows a GFP bipolar cell (BP) spanning the
carrying the transgene (negative control) does not express GFP. (F) Weak ba
The bar in panel C represents 30 lm. Outer nuclear layer (ONL), inner nucPrevious studies on mammalian retina have only detected a0-
PDE expression in photoreceptors, although low-level ex-
pression in some bipolar cells cannot be excluded [6]. A search
of the Xenopus tropicalis genome site (http://genome.jgi-
psf.org/xenopus0/xenopus0.info.html, v.2.0) identiﬁed a puta-
tive gene with homology to the human a0-PDE (data not
shown). However, antibodies to the mammalian a0-PDE did
not cross-react with the Xenopus protein (data not shown). The
possible expression of this gene in bipolar cells remains to be
elucidated. Previous studies by others and us have suggested a
relationship between cones and a subset of bipolar cells. For
example, we have shown that XOtx5b, the Xenopus ortholog of
mammalian Crx, is also expressed in photoreceptors and a
subset of bipolar cells [26]. This also appears to be the case for
zebraﬁsh Crx [27]. Futhermore, transgenic mice carrying the
blue cone opsin promoter expressed a reporter gene in both
blue cones and bipolar cells [28,29]. Taken together, the results
presented here suggest the possibility that cones and some
bipolar cells may share a common regulatory mechanism that
can activate the minimal a0-PDE ()132/+139) promoter. The
native a0-PDE promoter may contain additional sequences
that function as targets for repressor(s) to prevent expression
outside of cones. Results from studies on the opsin promoter
provide support for this type of mechanism. We found that a
closely related family member, Otx2, which is expressed in
bipolar cells, blocks the ability of Otx5b to bind to the opsin
promoter and activate transcription [26]. It is possible that
the a0-PDE upstream region may contain such cis-acting
sequences.
The most signiﬁcant ﬁnding of this report is the identiﬁca-
tion of a short 271 bp fragment of human DNA that can direct
reporter gene expression to cone but not rod photoreceptors in
Xenopus tadpoles. Previously, we had obtained similar results
using the mouse cone arrestin promoter, but there was also
expression in many other Xenopus tissues [30]. Mouse IRBP 50in a subset of bipolar cells. (A) A graph representing the ratio of GFP-
A schematic of a retinal section showing the region where cell counts
. Arrows point to the boundaries of the approximate region where cells
t expresses GFP mostly in inner nuclear layer cells (arrows) and a few
INL. (C and E) Rhodopsin-positive cells are red. (D, E) Sibling not
ckground auto-ﬂuorescence can be seen in the sibling negative control.
lear layer (INL) and ganglion cell layers (GCL).
264 A.S. Viczian et al. / FEBS Letters 577 (2004) 259–264upstream regulatory sequences directed reporter gene expres-
sion in a more restrictive pattern in transgenic frogs, but both
rods and cones expressed the transgene [31]. This is the ﬁrst
report of a mammalian cone promoter directing expression to
frog cone photoreceptors. Our study emphasizes the impor-
tance of using transgenic frogs and highlights the value of the
human a0-PDE regulatory region for studying cone tran-
scriptional gene regulation.
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